Psychiatric TimesPTSD in Late Life: Special IssuesPsychiatric TimesThe Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational institution announced that the FDA had recently granted methylenedioxymethamphetamine (MDMA)-assisted psychotherapy a Breakthrough Therapy ...